Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody

European Respiratory Journal

Volumn 10, Issue 6, 1997, Pages 1405-1407

  Ohtsuka, M ^a   Yamashita, Y ^a   Doi, M ^b   Hasegawa, S ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

Author keywords

Alveolar haemorrhage; Anti neutrophil cytoplasmic antibody; Propyl thiouracil; Vasculitis

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL;

ADULT; ARTICLE; CASE REPORT; ENZYME SPECIFICITY; FEMALE; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; LEUKOPENIA; LUNG HEMORRHAGE; LUNG INFILTRATE; LUPUS ERYTHEMATOSUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; VASCULITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HEMORRHAGE; HUMANS; LUNG DISEASES; PEROXIDASE; PROPYLTHIOURACIL;

EID: 0030975090     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Miyazono R, Okazaki T, Uchida S, et al. Propylthiouracil-induced diffuse interstitial pneumonitis. Arch Intern Med 1984; 144: 1764-1765.
2. Chevrolet JC, Guelpa G, Schifferli JA. Recurrent adult respiratory distress-like syndrome associated with propylthiouracil therapy. Eur Respir J 1991; 4: 899-901.
3. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-652.
4. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 1994; 124: 986-988.
5. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases. Am J Kidney Dis 1995; 26: 774-780.
6. Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 1992; 102: 1595-1596.
7. Bosch X, Font J, Mirapeix E, Revert L, Ingelmo M, Urbano-Márquez A. Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis. Am Rev Respir Dis 1992; 146: 1326-1329.
8. Bosch X, Lopez-Soto A, Mirapeix E, et al. Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 1994; 118: 517-522.
9. Romas E, Henderson DRF, Kirkham BW. Propylthiouracil therapy: an unusual cause of antineutrophil cytoplasmic antibody associated alveolar hemorrhage (Letter). J Rheumatol 1995; 22: 803.
10. Schmiedeberg SV, Goebel C, Gleichmann E, Uetrecht J. Neutrophils and drug metabolism. Science 1995; 268: 585-586.
11. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266: 810-813.
12. Cambridge GC, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994; 33: 109-114.
13. Lee E, Miki Y, Katsura H, Kariya K. Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem Pharmacol 1990; 39: 1467-1471.